Investigational Site Number : 3920003

Osaka, Osaka 541-8567

0 studies enrolling now · 2 studies all time

What they study most

Chronic Obstructive Pulmonary Disease, Non-small Cell Lung Cancer Metastatic

Studies at this site

• SAR408701 Versus Docetaxel in Previously Treated, Carcinoembryonic Antigen-related Cell Adhesion Molecule 5 (CEACAM5) Positive Metastatic Non-squamous Non-small-cell Lung Cancer Patients — Stopped early
• Study to Assess the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab in Chronic Obstructive Pulmonary Disease (COPD) — Completed